CalciMedica, Inc.: 5%+ holders

As of November 9, 2026, 7 holders' latest Schedule 13D or 13G filings report owning 5% or more of CalciMedica, Inc. The largest reported stake is Alafi Capital Company LLC's, at 19.9%. 19 filings are on record since August 5, 2025 (Schedule 13D/A, August 24, 2026).

Soleus Private Equity Fund III, L.P. also filed stake reports on 5 other companies ↓

Sell to companies like CalciMedica, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Your website Find my buyers

Opens in a new tab. No signup.

Key facts

• Filing 2026-08-25 · Reporting person: Stonepine Capital Management, LLC · Sole voting: 0 · Shared voting: 2,149,522 · Sole dispositive: 0 · Shared dispositive: 2,149,522 · SCHEDULE 13G, 2026-08-25
• Filing 2026-08-24 · Reporting person: Alafi Capital Company LLC · Sole voting: 0 · Shared voting: 7,220,101 · Sole dispositive: 0 · Shared dispositive: 7,220,101 · SCHEDULE 13D/A, 2026-08-24
• Filing 2026-08-21 · Reporting person: Bering Partners II GP, L.L.C. · Sole voting: 0 · Shared voting: 3,553,398 · Sole dispositive: 0 · Shared dispositive: 3,553,398 · SCHEDULE 13D/A, 2026-08-21
• Filing 2026-08-14 · Reporting person: Armistice Capital, LLC · Sole voting: 0 · Shared voting: 3,411,361 · Sole dispositive: 0 · Shared dispositive: 3,411,361 · SCHEDULE 13G, 2026-08-14
• Filing 2026-08-14 · Reporting person: Woodline Partners LP · Sole voting: 2,489,729 · Shared voting: 0 · Sole dispositive: 2,489,729 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-14

CalciMedica, Inc. has 19 Schedule 13D or 13G filings on record since 2025-08-05. 7 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Swipe the table sideways to see every column.

Holding shares or following this stake? See who's behind CalciMedica, Inc. and the warning signs.

See CalciMedica, Inc.'s free Snapshot Watch CalciMedica, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on CalciMedica, Inc. and the records around it.

CalciMedica, Inc. elsewhere on the record

• Leadership changes Aug 2026
• Who owns it

Companies that share a holder

• Soleus Private Equity Fund III, L.P. also filed stake reports on 5 other companies: Prelude Therapeutics Inc (Jul 2026), Aprea Therapeutics, Inc. (Apr 2026), INVIVYD, INC. (Feb 2026)
• Chernett Jorey also filed stake reports on 16 other companies: CVRx, Inc. (Oct 2026), WW INTERNATIONAL, INC. (Aug 2026), Neuronetics, Inc. (Aug 2026)
• Stonepine Capital Management, LLC also filed stake reports on 17 other companies: Femasys Inc (Aug 2026), Edesa Biotech, Inc. (Aug 2026), AEON Biopharma, Inc. (Jul 2026)

Want the whole picture on CalciMedica, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on CalciMedica, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on CalciMedica, Inc. covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   21 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Swipe the table sideways to see every column.

The latest filing identifies CalciMedica, Inc. by CUSIP 38942Q202 and gives its principal executive office as 505 Coast Boulevard South, Suite 300-9, La Jolla, CA 92037 (SCHEDULE 13G, 2026-08-25).

Source of funds (Item 3)

Item 3 of the Original Schedule 13D is hereby amended by the addition of the following information: The Stockholder Approval for the issuance of the Series A Warrants and Series B Warrants was obtained on August 19, 2026, and the Series A Warrants and Series B Warrants held by Bering II were issued on the same day.Bering Partners II GP, L.L.C., SCHEDULE 13D/A, 2026-08-21

Item 3 is hereby amended supplemented by adding the following at the end of Item 3: Open-Market Purchases Since November 6, 2024, Mr. Roberts and Ms. Leheny have made purchases of Common Stock in open market transactions using their personal funds. Such transactions are described in greater detail in Item 5 below.Valence Investments SPV VI, LLC, SCHEDULE 13D/A, 2026-06-30

Purpose of Transaction (Item 4)

Alafi Capital Company LLC

NoneItem 4 of the SCHEDULE 13D/A filed 2026-08-24

Bering Partners II GP, L.L.C.

The information set forth in Item 4 of the Original Schedule 13D is incorporated herein by reference.Item 4 of the SCHEDULE 13D/A filed 2026-08-21

Timeline

Swipe the table sideways to see every column.

Questions about who owns CalciMedica, Inc.

Who owns CalciMedica, Inc.?

On this page, 7 holders' latest ownership filings report 5% or more of CalciMedica, Inc.: Alafi Capital Company LLC (19.9%, Schedule 13D/A, filed 2026-08-24), Bering Partners II GP, L.L.C. (9.99%, Schedule 13D/A, filed 2026-08-21), Armistice Capital, LLC (9.99%, Schedule 13G, filed 2026-08-14), Woodline Partners LP (8.1%, Schedule 13G, filed 2026-08-14) and Valence Investments SPV VI, LLC (6.4%, Schedule 13D/A, filed 2026-06-30); 2 more are listed above.

Who are the largest shareholders of CalciMedica, Inc.?

By the share each holder's latest filing reports, the largest holders of CalciMedica, Inc. on this page are Alafi Capital Company LLC (19.9%), Bering Partners II GP, L.L.C. (9.99%) and Armistice Capital, LLC (9.99%).

When did Alafi Capital Company LLC buy into CalciMedica, Inc.?

The filings give report dates, not purchase dates. The earliest filing from Alafi Capital Company LLC on this page is the Schedule 13D, filed 2026-07-10, reporting 17.1%; its latest, Schedule 13D/A filed 2026-08-24, reports 19.9%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 19 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Also on the record for CalciMedica, Inc.

Swipe the table sideways to see every column.

Tools for this story

Each opens in a new tab, filled in for CalciMedica, Inc.. With no account yet, you sign up free and land on the result.

• Get an alert when CalciMedica, Inc. is mentioned again
• Find former CalciMedica, Inc. employees to interview
• Verify a claim or statistic

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes